ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 677261 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 677261; 2) Community: the network communities that were significantly associated with the response to NSC 677261; 3) Molecule: the relationships between components within communities and NSC 677261; 4) MDR: the compounds that were significantly associated with the NSC 677261.

NSC Compound Enrichment Correlation
NSC 741107 6-(3-Aminopropyl)-9-cyano-5,6-dihydro-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0244718705444139 -0.0019665547
NSC 749193 Null 0.0244718705444139 0.094739615
NSC 756364 GW805758X 0.0244718705444139 0.04949171
NSC 685470 Null 0.0246753314031138 0.41232357
NSC 638265 Null 0.0246753314031139 0.37352314
NSC 669145 2-Butenoic acid, 2-methyl-, 2,3,3a,4,5,6,7,11a-octahydro- 6,10-dimethyl-3-methylene-2,7-dioxo-6,9-epoxycyclodeca[b]furan-4-yl ester, [3aR-[3aR*,4S*(Z),6R*,10Z,11aR*]]- 0.0246753314031139 0.55426003
NSC 144173 Quinoxaline, 2,3-bis(iodomethyl)-6-methoxy- 0.0248868750898605 0.55180866
NSC 2604 D.b.t.c. 0.0248868750898605 0.42508437
NSC 625498 4-Morpholinecarbodithioic acid, antimony complex 0.0248868750898605 0.33102277
NSC 632790 Platinum, dichloro(quinoline-N)[sulfinylbis(methane)-S]-, (SP-4-1) 0.0248868750898605 0.56600594
Total:88  Current:51    [First] [Prev] [Next] [Last]